Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
36.38
-0.16 (-0.44%)
At close: Dec 5, 2025, 4:00 PM EST
37.29
+0.91 (2.50%)
After-hours: Dec 5, 2025, 7:56 PM EST
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,294 employees as of December 31, 2024. The number of employees increased by 18 or 1.41% compared to the previous year.
Employees
1,294
Change (1Y)
18
Growth (1Y)
1.41%
Revenue / Employee
$487,325
Profits / Employee
-$448,090
Market Cap
3.50B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RARE News
- 3 days ago - Ultragenyx Pharmaceutical Inc. (RARE) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 3 days ago - Ultragenyx Pharmaceutical Inc. (RARE) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Ultragenyx Pharmaceutical Inc. (RARE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $400 Million to OMERS Life Sciences - GlobeNewsWire
- 5 weeks ago - Ultragenyx to Host Conference Call for Third Quarter 2025 Financial Results and Corporate Update - GlobeNewsWire
- 6 weeks ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President - GlobeNewsWire
- 2 months ago - Ultragenyx Pharmaceutical Inc. (RARE) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha